TARGeted therapy using intradermal injection of ETanercept to treat Discoid Lupus Erythematosus (TARGET-DLE)

Mise à jour : Il y a 5 ans
Référence : EUCTR2015-001602-33

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To assess the proportion of patients with active discoid lupus erythematosus (DLE) that achieves a clinical response as assessed using the modified Limited Score of Activity and Damage in DLE (SADDLE) tool (ie: defined as reduction in modified limited SADDLE score by 20% or more from baseline in the discoid lesion) at Week 12 following treatment with weekly intra-dermal injection of etanercept.


Critère d'inclusion

  • Discoid lupus erythematosus

Liens